Piper Sandler Maintains Overweight on MDxHealth, Lowers Price Target to $6-Report released on 8th Nov 2023
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler analyst Jason Bednar has maintained an Overweight rating on MDxHealth (NASDAQ:MDXH) but lowered the price target from $10 to $6.
November 09, 2023 | 8:06 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Piper Sandler has maintained an Overweight rating on MDxHealth but lowered the price target from $10 to $6.
The lowering of the price target by Piper Sandler from $10 to $6 indicates a potential decrease in the stock's value. However, the maintained Overweight rating suggests that the stock is still expected to outperform.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100